Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.275 USD | -0.09% |
|
-13.58% | -14.84% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 52 | 100.0 % | 124 | 100.0 % | +138.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
66.9
%
| 16 | 29.9 % | 83 | 66.9 % | +433.82% |
Asia Pacific
33.0
%
| 37 | 70.0 % | 41 | 33.0 % | +12.58% |
North America
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | +90.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mike Raab Raab
CEO | Chief Executive Officer | 59 | 09-02-28 |
Justin Renz
DFI | Director of Finance/CFO | 52 | 20-06-08 |
Laura Williams
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-10-31 |
Chief Administrative Officer | 60 | 12-11-30 | |
Caitlin Lowie
IRC | Investor Relations Contact | - | 22-10-31 |
Charon Spencer
HRO | Human Resources Officer | - | 22-12-31 |
Robert Felsch
AUD | Comptroller/Controller/Auditor | - | 22-01-31 |
David Rosenbaum
PRN | Corporate Officer/Principal | 63 | 09-12-31 |
Robert Blanks
LAW | General Counsel | 64 | 13-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Bertrand
BRD | Director/Board Member | 59 | 15-10-25 |
Richard Rodgers
BRD | Director/Board Member | 57 | 14-02-28 |
David Mott
CHM | Chairman | 58 | 09-02-28 |
Mike Raab Raab
CEO | Chief Executive Officer | 59 | 09-02-28 |
Director/Board Member | 60 | 20-03-11 | |
Robert Bazemore
BRD | Director/Board Member | 56 | 16-06-01 |
Muna Bhanji
BRD | Director/Board Member | 61 | 21-03-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 233,976,572 | 229,986,641 ( 98.29 %) | 0 | 98.29 % |
Company contact information
![address Ardelyx, Inc.(ARDX)](https://cdn.zonebourse.com/static/address/16717109.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.84% | 1.24B | |
+15.22% | 122B | |
+16.07% | 113B | |
+17.55% | 26.22B | |
-24.14% | 19.01B | |
-19.14% | 15.71B | |
-17.75% | 15.22B | |
-46.81% | 14.72B | |
+57.33% | 14.58B | |
+4.83% | 13.84B |
- Stock Market
- Equities
- ARDX Stock
- Company Ardelyx, Inc.